SDC1 and breast cancer: A cell surface heparin sulfate proteoglycan known as syndecan-1 has been reported to function in cancer cell signaling and exosomes from cells expressing this proteoglycan have shown to contain a miRNA (miR-485) that was both upregulated in A549 cells [32], while another study reported this miRNA as downregulated in breast cancer tissue [33].